Horacio Plotkin

All filings by Horacio Plotkin on record concern Travere Therapeutics, Inc. We count 4 filings; the first trade dates from 15 August 2013 and the latest from 12 December 2014.

On the open market, the record shows 1 purchase worth €7,414 and 2 sales worth €80k. Taken together, the sales exceed the purchases by €72k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. 2014 to date brings no purchases and 2 sales.

The latest filing, published on 16 December 2014, reports an open-market sale of €17k in Travere Therapeutics, Inc. The most recent open-market purchase was published on 23 August 2013, 4,826 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.